Massachusetts General Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2020

  1. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

    Biological Psychiatry, Vol. 87, Núm. 2, pp. 100-112

2017

  1. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

    The Lancet, Vol. 390, Núm. 10102, pp. 1585-1594

1996

  1. Histologic transformation of benign endometriosis to early epithelial ovarian cancer

    Gynecologic Oncology, Vol. 60, Núm. 2, pp. 238-244

1995

  1. Cleavage of Mullerian Inhibiting Substance Activates Antiproliferative Effects in VIVO

    Clinical Cancer Research, Vol. 1, Núm. 3, pp. 343-349